Glenn Pfeffer, M.D., director of the Foot and Ankle Center at Cedars-Sinai Medical Center, has been elected president of the California Orthopaedic Association, an organization representing more than 2,000 orthopaedists in California. Pfeffer, who is also co-director of the Cedars-Sinai/USC Dance Medicine Center, will serve as the organization’s leader for a one-year term beginning in June 2010.
Psychiatrists should be included in disaster first-response teams because survivors have immediate need for help in alleviating early trauma symptoms ranging from sleeplessness to constant anxiety, says a new study of 9/11 survivors and victims’ family members published today in the Journal of Psychiatric Practice.
New research by scientists at Cedars-Sinai’s Maxine Dunitz Neurosurgical Institute suggests that a drug currently approved to treat erectile dysfunction may significantly enhance the delivery of the anti-cancer drug Herceptin to certain hard-to-treat brain tumors. The research, published in the current issue of the journal PLoS ONE, could help doctors improve treatments for lung and breast cancers that have metastasized to the brain.
New Cedars-Sinai research shows obese patients who test positive for methane on their breath have a significantly higher body mass index (BMI) than their peers.
High doses of antioxidant nutritional supplements, such as vitamins C and E, can increase genetic abnormalities in cells, which may predispose supplement-takers to developing cancer, according to a new study from the Cedars-Sinai Heart Institute.
A targeted antibiotic provides effective and long-lasting relief of Irritable Bowel Syndrome symptoms, according to the results of two multisite Phase III clinical trials designed by Cedars-Sinai researchers. Rifaximin is the first drug treatment for IBS that relieves symptoms while it’s being administered and continues to benefit patients after they stop taking the drug.
It was just two years ago this month that Michele Norlin, financial aid director at the Chadwick School in Palos Verdes, was diagnosed with amyotrophic lateral sclerosis (ALS). While a large part of her job for the past 14 years has been to help students gain a better education that will prepare them for life, she now hopes that by telling her story, she will help educate the public about ALS and the role stem cell research may provide in finding a cure for this debilitating disease. [May is ALS Awareness Month]
Physician scientists at the Cedars-Sinai Heart Institute are presenting new findings on heart transplantation rejection factors such as race and gender, the effects of pre-transplant smoking and whether homeless organ donors put recipients at higher risk for complications. The presentations will take place April 21 – 24 in Chicago during the 30th Annual Scientific Meeting of the International Society of Heart and Lung Transplantation.
Researchers at the Cedars-Sinai Heart Institute have found in animals that infusing cardiac-derived stem cells with micro-size particles of iron and then using a magnet to guide those stem cells to the area of the heart damaged in a heart attack boosts the heart’s retention of those cells and could increase the therapeutic benefit of stem cell therapy for heart disease.
Patients suffering from recently diagnosed malignant brain tumors called glioblastoma multiforme or a rare variant called gliosarcoma may be eligible to participate in a Phase II clinical trial at Cedars-Sinai Medical Center that combines two innovative drugs.
In a rigorous new review of the antiarrhythmic drug dronedarone (Multaq), researchers at the Cedars-Sinai Heart Institute conclude that the controversial drug is only modestly effective and has no clear safety benefits. The review, to be published in the April 23 issue of the Journal of the American College of Cardiology, assessed data on dronedarone submitted during the drug's FDA approval process and determined that dronedarone is 50 percent less effective than amiodarone (Cordarone), a frequently used treatment for atrial fibrillation, a common type of heart rhythm disorder.
While health policy researchers commonly suggest that geographic variations in the amount of medical care provided can be attributed to hospital costs or physician practice patterns, a new study examining regional utilization of a specific surgical procedure – minimally invasive aneurysm repair – shows that is not the case.
Physician-scientists at the Cedars-Sinai Heart Institute have found that a genetic variation is associated with lower risk of sudden cardiac arrest, a disorder that gives little warning and is fatal in about 95 percent of cases. Findings will be published tomorrow by the Public Library of Science (PloS One).
You see pictures of a monkey, scrambled eggs and a brightly dressed group of women laughing. Research scientists at Cedars-Sinai Medical Center and the California Institute of Technology see electrical spikes coming from the neurons of your brain.
A Cedars-Sinai Heart Institute cardiologist has been awarded a three-year, nearly $1 million grant from the Muscular Dystrophy Association (MDA) to study whether drugs used to treat erectile dysfunction could also be used to improve muscle blood flow and reduce fatigue in muscular dystrophy patients.
The number of living donor organs available for transplant has progressively declined over the past five years, according to a new study. In addition, the study showed that for the first time, organs from deceased donors decreased in 2008.
Patients who suffer from plaque-related narrowing of a carotid artery but are not good candidates for open surgery may be eligible to participate in a clinical trial at Cedars-Sinai Medical Center of a minimally invasive procedure designed to open carotid arteries the way angioplasty and stenting clear arteries of the heart.
Individuals between 30 and 80 years of age, who have had a transient ischemic attack (TIA) or non-severe stroke within the past 30 days, and who cannot be treated surgically, may be eligible to participate in a Phase III clinical trial of a minimally invasive stenting procedure at the Cedars-Sinai Neurovascular Center.
A study questions the effectiveness of routine aspirin therapy in preventing heart disease, while another suggests that LVADs may aid in weight loss for obese patients awaiting a heart transplant.
A study of the human genome led by Cedars-Sinai researchers has now identified genes linked to ulcerative colitis, offering clues as to what causes the condition and potential avenues for new therapies to treat the disease.
On March 21, Benny Zafrani will be running the Los Angeles Marathon. That, by itself, is not remarkable – after all, thousands of others will be doing the same thing. However, Benny is on a mission to raise funds for pediatric brain tumor research. And his mission was spurred by personal experience.
Researchers at Cedars-Sinai Medical Center in Los Angeles, the University of California, San Diego School of Medicine, and UTHealth’s Medical School will collaborate on the largest clinical trial of hypothermia (brain cooling) for stroke to date. The ICTuS 2 study (Intravascular Cooling for Acute Stroke) will be led by overall principal investigator Patrick D. Lyden, M.D., former director of the UC San Diego Stroke Center and currently chairman of the Department of Neurology at Cedars-Sinai.
A Cedars-Sinai Heart Institute cardiologist co-authored the joint science advisory issued by the American Heart Association and the American College of Cardiology that calls for close monitoring of patients taking certain blood sugar-lowering drugs.
Jon Kobashigawa, M.D., director of Cedars-Sinai Heart Institute’s Heart Transplant Program and an internationally-recognized leader in the care of patients with advanced heart failure, has been named the inaugural holder of the DSL/Thomas D. Gordon Endowed Chair in Heart Transplantation Medicine.
About 120 students from four area schools will begin to discover if they have what it takes to become brain surgeons or neuroscientists through hands-on experience at Cedars-Sinai Medical Center Friday, Feb. 26, 2010. Excellent Photo Opportunities.
Clive Svendsen, Ph.D., director of the Cedars-Sinai Regenerative Medicine Institute, is receiving the American Academy of Neurology Sheila Essey Award for his research on ALS (amyothrophic lateral sclerosis).
Fat tissue in women with Polycystic Ovary Syndrome produces an inadequate amount of the hormone that regulates how fats and glucose are processed, promoting increased insulin resistance and inflammation, glucose intolerance, and greater risk of diabetes and heart disease, according to a study conducted at the Center for Androgen-Related Research and Discovery at Cedars-Sinai Medical Center.
The California Heart Center, the cardiology group that developed the nation’s largest heart transplant program, has joined the Cedars-Sinai Heart Institute and Cedars-Sinai Medical Care Foundation.
Worth magazine has selected Cedars-Sinai Heart Institute as one of the United States’ top 25 hospitals for cardiac bypass surgery.
Using laboratory mice that had been bred to have brain changes similar to Alzheimer’s disease, scientists were able to reduce two characteristic features of the disease by modifying the mice’s immune systems with a special peptide (MOG45D) related to the myelin sheath that insulates nerve cells and nerve fibers. As a result, anti-inflammatory cells were recruited from the blood into the brain, dampening the local inflammatory response.
The Cedars-Sinai Center for Weight Loss has received re-accreditation as a Bariatric Surgery Center of Excellence from the American College of Surgeons. This is a nationally–recognized acknowledgement of the high quality of care provided at Cedars-Sinai to patients who have bariatric surgery - such as lap-band, gastric sleeve or gastric bypass.
The Cedars-Sinai Regenerative Medicine Institute is to provide stem cells to a five-member National Institutes of Health consortium of researchers for development of potential therapies to treat Huntington’s disease.
Thanks to Los Angeles County’s new Emergency Stroke System, individuals who experience a stroke may now be able to more quickly access some of the latest advances in stroke interventions. The Emergency Medical Services Agency announced that ambulances will transport suspected stroke patients directly to Approved Stroke Centers in Los Angeles County. These are facilities that are specially stroke-prepared – medically and surgically – and have the mechanisms in place to quickly provide the right treatment.
Marla C. Dubinsky, M.D., director of the Cedars-Sinai Pediatric Inflammatory Bowel Disease Center and one of the world’s leading researchers studying the disease, has been named the Abe and Claire Levine Chair in Pediatric Inflammatory Bowel Disease.
Relief from decades of low back pain gives Carole Riggs even more to celebrate during the holidays – Riggs, a retired teacher and school principal, points to her work during one Christmas vacation – bending, twisting and sitting on the floor to create games and teaching aids – as the primary culprit behind many years of back pain.
New findings from the Oregon Sudden Unexpected Death Study show women don’t exhibit signs that would make them eligible for current treatments to prevent fatal cardiac arrest.
William Ganz, M.D., an internationally-recognized leader and inventor in heart medicine, died Tuesday night of natural causes. He was 90.
C. Noel Bairey Merz, M.D., an internationally recognized authority on women’s heart health, will receive the American Heart Association’s 2009 Women in Cardiology Mentoring Award at the organization’s Scientific Sessions 2009, to be held in Orlando at the Orange County Convention Center Nov. 14-Nov. 18.
A team from Cedars-Sinai Medical Center will be meeting with leaders in medicine and health insurance and as well as patients during a visit to Guam this week. The aim of the trip is to continue to strengthen relationships with healthcare leaders and patients.
A team of Cedars-Sinai Heart Institute stem cell researchers led by Eduardo Marbán, M.D., Ph.D. has been awarded a four-year, $5.5 million grant from the California Institute of Regenerative Medicine (CIRM) to fund research leading to clinical trials of new treatments for heart attack patients.
The results from a current study, published in the Journal of Cellular and Molecular Medicine, suggest that premature aging of the immune system appears to play a role in the development of ALS. The researchers found that thymic malfunction occurs simultaneously with motor neuron dysfunction, both in laboratory mice bred to mimic amyotrophic lateral sclerosis and in humans suffering from the disease.
A simple, non-invasive test appears to be an effective screening tool for identifying patients with silent heart disease who are at risk for a heart attack or sudden death. Coronary artery calcium scans can be done without triggering excessive additional testing and costs, according to the multi-center EISNER study, led by investigators at the Cedars-Sinai Heart Institute.
Panel to discuss how healthcare reform could affect cardiovascular medical advances; conference will also feature seminars on breakthrough non-surgical techniques for valve repair and replacements as well as stem cell and gene therapies and presentations from British and American doctors highlighting how their country’s medical insurance system affects patient treatment.
Wildfires present special health hazards to humans and pets – especially children, the elderly, and those with chronic respiratory problems such as emphysema, asthma, congestive heart failure, chronic obstructive pulmonary disease (COPD) and others. Tipsheet available from Cedars-Sinai Medical Center.
Neurosurgeon Keith L. Black, M.D., will receive a Pioneer in Medicine Award at the World Congress of the International Brain Mapping & Intraoperative Surgical Planning Society (IBMISPS).
Dorys Balboa spent 11 years in pain after injuring her low back. Finally, decompression surgery performed at Cedars-Sinai Medical Center last year brought immediate, complete relief.
The Cedars-Sinai Medical Center’s Medical Genetics Institute and Department of Pathology and Laboratory Medicine will be the first to offer genetic screenings for four common inherited disorders within the Persian Jewish population.
Greg Traylor was just 46 years old when he suffered a debilitating stroke. Today, he's on a mission to raise stroke prevention awareness in the African-American community. According to the National Stroke Association, African-Americans are affected by stroke more often than any other group. They are twice as likely as Caucasians to die from stroke, and one half of all African-American women will die from stroke or heart disease.
Symptomatic uterine fibroids can have a significant effect on a patient's quality of life. A non-surgical procedure known as uterine fibroid embolization (UFE) is becoming increasingly popular as more women are learning about it.
Cancer stem-like cells have been implicated in the genesis of a variety of malignant cancers. Research scientists at Cedars-Sinai Medical Center's Maxine Dunitz Neurosurgical Institute have isolated stem-like cells in benign (pituitary) tumors and used these "mother" cells to generate new tumors in laboratory mice. Targeting the cells of origin is seen as a possible strategy in the fight against malignant and benign tumors.
RSS
Medicine keyboard_arrow_right
Sciencekeyboard_arrow_right
Life keyboard_arrow_right
Business keyboard_arrow_right
Journal News keyboard_arrow_right
By Location keyboard_arrow_right
Meetings, Grants, and Events keyboard_arrow_right